Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Initiates EPS Guidance for 2015

NEW YORK(GenomeWeb) — Danaher today initiated guidance for adjusted diluted EPS for 2015 in the range of $4.35 to $4.45. 

The guidance assumes core revenue growth of 3 percent to 4 percent and excludes anticipated non-cash amortization for 2015 of $440 million, or $.46 per share, compared to about $380 million, or $40 per share, in 2014.  

The company also reaffirmed GAAP diluted EPS for the fourth quarter of 2014 to be in the range of $1 to $1.04. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.